Search results
Axsome (AXSM) Stock Up 17% in Six Months: Here's Why
Zacks via Yahoo Finance· 1 year agoAxsome's (AXSM) shares have surged 17.2% in the past six months, owing to the launch of its first product, Auvelity, in October last year. Also, the...
Axsome Therapeutics (AXSM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Zacks via Yahoo Finance· 3 months agoAxsome (AXSM) possesses the right combination of the two key ingredients for a likely earnings beat...
Axsome (AXSM) Upgraded to Strong Buy: Here's What You Should Know
Zacks via Yahoo Finance· 10 months agoAxsome (AXSM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about...
Axsome Therapeutics, Inc. (NASDAQ:AXSM) drops to US$1.1b and insiders who purchased earlier this...
Simply Wall St. via Yahoo Finance· 2 years agoInsiders who bought US$374k worth of Axsome Therapeutics, Inc.'s (NASDAQ:AXSM) stock at an average...
Axsome (AXSM) Begins Dosing in Depression Study on Sunosi
Zacks via Yahoo Finance· 1 month agoAxsome (AXSM) doses the first patient in the phase III PARADIGM study evaluating Sunosi...
Why Axsome (AXSM) is Up 7% Despite Wider-Than-Expected Q1 Loss
Zacks via Yahoo Finance· 2 years agoAxsome (AXSM) reports a slightly wider-than-estimated Q1 loss. It expects to receive FDA approval...
Relmada Tanks After 'Paradoxical Results' Undermine Depression Drug; Axsome Surges
Investor's Business Daily· 2 years agoRelmada Therapeutics stock crashed Thursday after its depression treatment failed a final-phase...
Axsome (AXSM) Q2 Loss Narrower Than Expected, Revenues Miss
Zacks via Yahoo Finance· 2 years agoAxsome (AXSM) reports narrower-than-expected loss for the second quarter of 2022. The company...
Biotech Stock Roundup: GILD, BLUE, AXSM's Drug Approvals, FHTX Study Update & More
Zacks via Yahoo Finance· 2 years agoDrug approvals and other regulatory updates are in focus in the biotech sector. COVID-19 vaccine...
Teva Plots Its Knockoff Of Axsome's New Depression Drug, Sending The Biotech Sprawling
Investor's Business Daily· 1 year agoTeva Pharmaceutical said Monday it plans a competing knockoff of Axsome Therapeutics' new depression...